By Izzy Wood (Drug Target Review)2023-05-17T14:56:59
US researchers have uncovered a potential target for treating breast cancer that is resistant to endocrine therapies because of a specific gene mutation.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-26T13:58:00Z
2024-02-01T11:52:50
Sponsored by Leica Microsystems
2024-01-10T08:56:17
Sponsored by Leica Microsystems
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2025-05-14T14:30:00
Sponsored by Abzena
2023-03-28T11:38:32
Sponsored by Bio-Techne
2023-11-20T13:43:43
Sponsored by Merck
Site powered by Webvision Cloud